Introduction
Background Information
Limitations of L. acidophilus as the species of choice in Lactobacillus therapy
Benefits of Bacillus coagulans as a probiotic
Clinical Studies
As a Veterinary probiotic
Toxicological aspects of LactoSpore®
Testing procedures & Stability
Summary
References
Glossary
Additional Recent Research Information
Contact Us
Home


LactoSpore® Genotyping studies

In addition to the phenotype characterization performed on LactoSpore®, the 16SrDNA studies have been carried out.

The Sabinsa probiotic strain #01 sent for the study was labeled as SBC37-01. This strain earlier characterized as Bacillus coagulans by phenotyping studies grows optimally at 370C.

The genotyping result also confirmed and identified the strain as Bacillus coagulans with a homology of 99.5% in consensus with Bacillus coagulans ATCC 7050.

 

sslogo.gif (1636 bytes)
©  Sabinsa Corporation 2010